Cargando…

Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19

Detalles Bibliográficos
Autores principales:	Zarrouki, Y, Rebahi, H, Rhezali, M, Douirek, F, Ziad, A, Samkaoui, M A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	South African Medical Association 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029743/ https://www.ncbi.nlm.nih.gov/pubmed/36960298 http://dx.doi.org/10.7196/SAJCC.2020.v36i1.449

Ejemplares similares

Síndrome inflamatorio multisistémico de tipo Kawasaki asociado a COVID-19 en un adulto
por: Elouardi, Y., et al.
Publicado: (2022)

COVID-19 associated Kawasaki-like multisystem inflammatory syndrome in an adult()
por: Elouardi, Y., et al.
Publicado: (2022)

Hydroxychloroquine: Torsades de pointes following off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Torsade-de-pointes following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades-de-pointes following off label treatment: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsades de pointes following off-label use: case report
Publicado: (2021)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

An unusual etiology of torsade de pointes-induced syncope
por: Morosin, Marco, et al.
Publicado: (2017)

To the Editor—COVID-19 vaccination and torsades de pointes
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cardiac arrest after tourniquet deflation in upper limb
por: Zarrouki, Y., et al.
Publicado: (2017)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Author’s Reply—COVID-19 vaccination and torsades de pointes
por: Abrich, Victor, et al.
Publicado: (2022)

A tale of 2 torsades: How to approach a patient with torsades de pointes and distinguish between classical and pseudo–torsades de pointes
por: Scheinman, Melvin, et al.
Publicado: (2022)

Sustained intraoperative bradycardia revealing Sengers syndrome
por: Zarrouki, Youssef, et al.
Publicado: (2017)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Methadone, Metoclopramide and Metronidazole Interaction Causing Torsades de Pointes
por: Gnanapandithan, Karthik, et al.
Publicado: (2021)

Ondansetron induced torsades de pointes
por: Patel, Eshan, et al.
Publicado: (2019)

Failure to Treat Torsades de Pointes
por: Yazdan-Ashoori, Payam, et al.
Publicado: (2012)

Loperamide-Induced Torsades de Pointes
por: Isang, Emmanuel, et al.
Publicado: (2021)

The ability of two scoring systems to predict in-hospital mortality of patients with moderate and severe traumatic brain injuries in a Moroccan intensive care unit
por: Nejmi, Hicham, et al.
Publicado: (2014)

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
por: Jankelson, Lior, et al.
Publicado: (2020)

Short‐term use of oral amiodarone causing torsades de pointes
por: Yau, Stephen, et al.
Publicado: (2018)

DRUGS, ELECTROLYTES AND TAKO-TSUBO CARDIOMYOPATHY: TRIPLE AETIOLOGY OF ACQUIRED LONG QT SYNDROME AND TORSADES DE POINTES
por: Purvis, John A, et al.
Publicado: (2009)

Torsades de pointes observed in the early postoperative period in a patient with long QT syndrome
por: Kim, Min-Soo, et al.
Publicado: (2013)

Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase
por: Saint-Gerons, Diego Macías, et al.
Publicado: (2021)

Nearly Fatal Torsade de Pointes with Sotalol
por: Strohmer, Bernhard, et al.
Publicado: (2003)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Leadless pacemaker–induced torsades de pointes
por: Burkman, Gregory, et al.
Publicado: (2020)

Amiodarone: Torsade de pointes: case report
Publicado: (2022)

Torsade de Pointes Due to Hypokalemia and Hypomagnesemia
por: Cabahug, Mary Crista, et al.
Publicado: (2022)

Torsades de pointes following vaccination for COVID-19
por: Abrich, Victor A., et al.
Publicado: (2022)

Class III Antiarrhythmics and Periprocedural Torsades de Pointes
por: Font, Cristina M., et al.
Publicado: (2023)

Torsades de Pointes in Coronavirus Disease 2019 Infection
por: Lalabekyan, Bagrat, et al.
Publicado: (2021)

Frequently occurring Torsades de pointes attacks in an old patient on solifenacin therapy and management strategy
por: Özmen, Namık, et al.
Publicado: (2015)

Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus
por: Prosser, Jane M., et al.
Publicado: (2008)

Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report
por: Cicci, Jonathan D, et al.
Publicado: (2019)

Phenytoin in treatment of amiodarone-induced Torsades de pointes
por: Mukhopadhyay, Saibal, et al.
Publicado: (2012)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ub5k6gp4nc3ouqab6vscvlon0v